Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
MLSS Milestone Scientific Inc
- Stocks
- Healthcare
- NYSEAMERICAN: MLSS
Price (delayed)
$0.8789
Market cap
$68.97M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.07
Enterprise value
$67.05M
Milestone Scientific Inc. is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary
Highlights
The debt has contracted by 14% YoY and by 9% from the previous quarter
The company's gross margin rose by 7% YoY
Milestone Scientific's EPS has increased by 30% YoY but it has decreased by 17% from the previous quarter
The net income has grown by 25% year-on-year but it has declined by 12% since the previous quarter
The company's quick ratio has shrunk by 60% YoY and by 38% QoQ
The equity has contracted by 40% YoY and by 23% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.milestonescientific.com
Key stats
What are the main financial stats of MLSS
Market
Valuations
Earnings
Shares outstanding
78.48M
Market cap
$68.97M
Enterprise value
$67.05M
Price to earnings (P/E)
N/A
Price to book (P/B)
15.34
Price to sales (P/S)
8.35
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.78
Revenue
$8.61M
Gross profit
$6.41M
Operating income
-$7.29M
Net income
-$5.27M
EBIT
-$5.29M
EBITDA
-$5.14M
Free cash flow
-$2.72M
Per share
Balance sheet
Liquidity
EPS
-$0.07
EPS diluted
-$0.07
Free cash flow per share
-$0.03
Book value per share
$0.06
Revenue per share
$0.11
TBVPS
$0.11
Total assets
$9.09M
Total liabilities
$4.63M
Debt
$318,697
Equity
$4.46M
Working capital
$4.18M
Debt to equity
0.07
Current ratio
1.94
Quick ratio
0.62
Net debt/EBITDA
0.37
Margins
Efficiency
Dividend
EBITDA margin
-59.7%
Gross margin
74.4%
Net margin
-61.2%
Operating margin
-84.6%
Return on assets
-50.1%
Return on equity
-82.7%
Return on invested capital
-192.6%
Return on capital employed
-113.9%
Return on sales
-61.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MLSS stock price
How has the Milestone Scientific stock price performed over time
Intraday
-0.07%
1 week
-0.13%
1 month
-16.3%
1 year
31.18%
YTD
-8.45%
QTD
-5.76%
Financial performance
How have Milestone Scientific's revenue and profit performed over time
Revenue
$8.61M
Gross profit
$6.41M
Operating income
-$7.29M
Net income
-$5.27M
Gross margin
74.4%
Net margin
-61.2%
The net income has grown by 25% year-on-year but it has declined by 12% since the previous quarter
The net margin has grown by 18% YoY but it has contracted by 12% from the previous quarter
The operating margin has declined by 11% year-on-year and by 8% since the previous quarter
The revenue is down by 9% year-on-year
Price vs fundamentals
How does MLSS's price correlate with its fundamentals
Growth
What is Milestone Scientific's growth rate over time
Valuation
What is Milestone Scientific stock price valuation
P/E
N/A
P/B
15.34
P/S
8.35
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.78
Milestone Scientific's EPS has increased by 30% YoY but it has decreased by 17% from the previous quarter
The P/B is 92% higher than the 5-year quarterly average of 8.0 and 35% higher than the last 4 quarters average of 11.4
The equity has contracted by 40% YoY and by 23% from the previous quarter
The P/S is 28% less than the 5-year quarterly average of 11.6 but 3.1% more than the last 4 quarters average of 8.1
The revenue is down by 9% year-on-year
Efficiency
How efficient is Milestone Scientific business performance
The company's return on invested capital fell by 31% YoY and by 26% QoQ
The return on equity has declined by 25% since the previous quarter but it has increased by 10% year-on-year
MLSS's ROA is up by 21% YoY but it is down by 18% QoQ
Milestone Scientific's ROS has increased by 18% YoY but it has decreased by 12% from the previous quarter
Dividends
What is MLSS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MLSS.
Financial health
How did Milestone Scientific financials performed over time
The total assets is 96% greater than the total liabilities
The company's quick ratio has shrunk by 60% YoY and by 38% QoQ
Milestone Scientific's current ratio has decreased by 35% YoY and by 22% from the previous quarter
The debt is 93% less than the equity
The equity has contracted by 40% YoY and by 23% from the previous quarter
Milestone Scientific's debt to equity has increased by 40% YoY and by 17% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.